Changes in Anti-Mullerian Hormone (AMH) throughout the Life Span: A Population-Based Study of 1027 Healthy Males from Birth (Cord Blood) to the Age of 69 Years

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Changes in Anti-Mullerian Hormone (AMH) throughout the Life Span: A Population-Based Study of 1027 Healthy Males from Birth (Cord Blood) to the Age of 69 Years. / Aksglæde, Lise; Sørensen, K; Boas, M.; Mouritsen, Annette Korsholm; Hagen, C.P.; Jensen, Rikke Bodin; Petersen, Jørgen Holm; Linneberg, A.; Andersson, A.M.; Main, K.M.; Skakkebæk, Niels Erik; Juul, A.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 95, No. 12, 2010, p. 5357-5364.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Aksglæde, L, Sørensen, K, Boas, M, Mouritsen, AK, Hagen, CP, Jensen, RB, Petersen, JH, Linneberg, A, Andersson, AM, Main, KM, Skakkebæk, NE & Juul, A 2010, 'Changes in Anti-Mullerian Hormone (AMH) throughout the Life Span: A Population-Based Study of 1027 Healthy Males from Birth (Cord Blood) to the Age of 69 Years', Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 12, pp. 5357-5364.

APA

Aksglæde, L., Sørensen, K., Boas, M., Mouritsen, A. K., Hagen, C. P., Jensen, R. B., ... Juul, A. (2010). Changes in Anti-Mullerian Hormone (AMH) throughout the Life Span: A Population-Based Study of 1027 Healthy Males from Birth (Cord Blood) to the Age of 69 Years. Journal of Clinical Endocrinology and Metabolism, 95(12), 5357-5364.

Vancouver

Aksglæde L, Sørensen K, Boas M, Mouritsen AK, Hagen CP, Jensen RB et al. Changes in Anti-Mullerian Hormone (AMH) throughout the Life Span: A Population-Based Study of 1027 Healthy Males from Birth (Cord Blood) to the Age of 69 Years. Journal of Clinical Endocrinology and Metabolism. 2010;95(12):5357-5364.

Author

Aksglæde, Lise ; Sørensen, K ; Boas, M. ; Mouritsen, Annette Korsholm ; Hagen, C.P. ; Jensen, Rikke Bodin ; Petersen, Jørgen Holm ; Linneberg, A. ; Andersson, A.M. ; Main, K.M. ; Skakkebæk, Niels Erik ; Juul, A. / Changes in Anti-Mullerian Hormone (AMH) throughout the Life Span: A Population-Based Study of 1027 Healthy Males from Birth (Cord Blood) to the Age of 69 Years. In: Journal of Clinical Endocrinology and Metabolism. 2010 ; Vol. 95, No. 12. pp. 5357-5364.

Bibtex

@article{a59bbfbc04fc4df78e081ad56c8a55ce,
title = "Changes in Anti-Mullerian Hormone (AMH) throughout the Life Span: A Population-Based Study of 1027 Healthy Males from Birth (Cord Blood) to the Age of 69 Years",
abstract = "Context: Anti-Mullerian hormone (AMH), which is secreted by immature Sertoli cells, triggers the involution of the fetal Mullerian ducts. AMH is a testis-specific marker used for diagnosis in infants with ambiguous genitalia or bilateral cryptorchidism. Aim: The aim of the study was to describe the ontogeny of AMH secretion through life in healthy males. Setting:This was a population-based study of healthy volunteers. Participants: Participants included 1027 healthy males from birth (cord blood) to 69 yr. A subgroup was followed up longitudinally through the infantile minipuberty [(in cord blood, and at 3 and 12 months), n = 55] and another group through puberty [(biannual measurements), n = 83]. Main Outcome Measures: Serum AMH was determined by a sensitive immunoassay. Serum testosterone, LH, and FSH were measured, and pubertal staging was performed in boys aged 6 to 20 yr (n = 616). Results: Serum AMH was above the detection limit in all samples with a marked variation according to age and pubertal status. The median AMH level in cord blood was 148 pmol/liter and increased significantly to the highest observed levels at 3 months (P <0.0001). AMH declined at 12 months (P <0.0001) and remained at a relatively stable level throughout childhood until puberty, when AMH declined progressively with adults exhibiting 3-4{\%} of infant levels. Conclusion: Based on this extensive data set, we found detectable AMH serum levels at all ages, with the highest measured levels during infancy. At the time of puberty, AMH concentrations declined and remained relatively stable throughout adulthood. The potential physiological role of AMH and clinical applicability of AMH measurements remain to be determined",
author = "Lise Aksgl{\ae}de and K S{\o}rensen and M. Boas and Mouritsen, {Annette Korsholm} and C.P. Hagen and Jensen, {Rikke Bodin} and Petersen, {J{\o}rgen Holm} and A. Linneberg and A.M. Andersson and K.M. Main and Skakkeb{\ae}k, {Niels Erik} and A. Juul",
year = "2010",
language = "English",
volume = "95",
pages = "5357--5364",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "Oxford University Press",
number = "12",

}

RIS

TY - JOUR

T1 - Changes in Anti-Mullerian Hormone (AMH) throughout the Life Span: A Population-Based Study of 1027 Healthy Males from Birth (Cord Blood) to the Age of 69 Years

AU - Aksglæde, Lise

AU - Sørensen, K

AU - Boas, M.

AU - Mouritsen, Annette Korsholm

AU - Hagen, C.P.

AU - Jensen, Rikke Bodin

AU - Petersen, Jørgen Holm

AU - Linneberg, A.

AU - Andersson, A.M.

AU - Main, K.M.

AU - Skakkebæk, Niels Erik

AU - Juul, A.

PY - 2010

Y1 - 2010

N2 - Context: Anti-Mullerian hormone (AMH), which is secreted by immature Sertoli cells, triggers the involution of the fetal Mullerian ducts. AMH is a testis-specific marker used for diagnosis in infants with ambiguous genitalia or bilateral cryptorchidism. Aim: The aim of the study was to describe the ontogeny of AMH secretion through life in healthy males. Setting:This was a population-based study of healthy volunteers. Participants: Participants included 1027 healthy males from birth (cord blood) to 69 yr. A subgroup was followed up longitudinally through the infantile minipuberty [(in cord blood, and at 3 and 12 months), n = 55] and another group through puberty [(biannual measurements), n = 83]. Main Outcome Measures: Serum AMH was determined by a sensitive immunoassay. Serum testosterone, LH, and FSH were measured, and pubertal staging was performed in boys aged 6 to 20 yr (n = 616). Results: Serum AMH was above the detection limit in all samples with a marked variation according to age and pubertal status. The median AMH level in cord blood was 148 pmol/liter and increased significantly to the highest observed levels at 3 months (P <0.0001). AMH declined at 12 months (P <0.0001) and remained at a relatively stable level throughout childhood until puberty, when AMH declined progressively with adults exhibiting 3-4% of infant levels. Conclusion: Based on this extensive data set, we found detectable AMH serum levels at all ages, with the highest measured levels during infancy. At the time of puberty, AMH concentrations declined and remained relatively stable throughout adulthood. The potential physiological role of AMH and clinical applicability of AMH measurements remain to be determined

AB - Context: Anti-Mullerian hormone (AMH), which is secreted by immature Sertoli cells, triggers the involution of the fetal Mullerian ducts. AMH is a testis-specific marker used for diagnosis in infants with ambiguous genitalia or bilateral cryptorchidism. Aim: The aim of the study was to describe the ontogeny of AMH secretion through life in healthy males. Setting:This was a population-based study of healthy volunteers. Participants: Participants included 1027 healthy males from birth (cord blood) to 69 yr. A subgroup was followed up longitudinally through the infantile minipuberty [(in cord blood, and at 3 and 12 months), n = 55] and another group through puberty [(biannual measurements), n = 83]. Main Outcome Measures: Serum AMH was determined by a sensitive immunoassay. Serum testosterone, LH, and FSH were measured, and pubertal staging was performed in boys aged 6 to 20 yr (n = 616). Results: Serum AMH was above the detection limit in all samples with a marked variation according to age and pubertal status. The median AMH level in cord blood was 148 pmol/liter and increased significantly to the highest observed levels at 3 months (P <0.0001). AMH declined at 12 months (P <0.0001) and remained at a relatively stable level throughout childhood until puberty, when AMH declined progressively with adults exhibiting 3-4% of infant levels. Conclusion: Based on this extensive data set, we found detectable AMH serum levels at all ages, with the highest measured levels during infancy. At the time of puberty, AMH concentrations declined and remained relatively stable throughout adulthood. The potential physiological role of AMH and clinical applicability of AMH measurements remain to be determined

M3 - Journal article

VL - 95

SP - 5357

EP - 5364

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 12

ER -

ID: 34048198